X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (965) 965
Paper (734) 734
Publication (581) 581
Report (124) 124
Data Set (8) 8
Newspaper Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (858) 858
particle physics (732) 732
high energy physics - experiment (693) 693
physics (693) 693
physics - high energy physics - experiment (660) 660
high energy physics (574) 574
phenomenology (366) 366
cern lhc coll (353) 353
experimental results (333) 333
physics of elementary particles and fields (274) 274
nuclear experiment (250) 250
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (234) 234
physical sciences (223) 223
fysik (222) 222
hep (210) 210
natural sciences (195) 195
naturvetenskap (195) 195
p p: scattering (193) 193
particle physics - experiment (181) 181
p p: colliding beams (179) 179
13000 gev-cms (165) 165
ex (158) 158
scattering [p p] (156) 156
hadron-hadron scattering (146) 146
subatomär fysik (138) 138
subatomic physics (137) 137
colliding beams [p p] (127) 127
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (123) 123
8000 gev-cms (115) 115
atlas (110) 110
astrophysics (106) 106
physics, particles & fields (102) 102
high energy astrophysical phenomena (96) 96
background (82) 82
elementary particles, quantum field theory (77) 77
quantum field theories, string theory (77) 77
science & technology (74) 74
ciências físicas [ciências naturais] (70) 70
collisions (58) 58
detectors (58) 58
mass dependence (58) 58
large hadron collider (53) 53
astronomy, astrophysics and cosmology (49) 49
transverse momentum dependence (49) 49
data analysis method (46) 46
物理学 (46) 46
nuclear and high energy physics (44) 44
measurement science and instrumentation (43) 43
nuclear energy (43) 43
parton distributions (43) 43
rapidity dependence (42) 42
supersymmetry (42) 42
bottom: particle identification (41) 41
instrumentation and detectors (41) 41
nuclear physics, heavy ions, hadrons (40) 40
physics and astronomy (38) 38
classical and quantum gravitation, relativity theory (37) 37
quantum physics (37) 37
cern lab (36) 36
jet: bottom (36) 36
kinematics (36) 36
settore fis/01 - fisica sperimentale (36) 36
z0: leptonic decay (36) 36
astronomy & astrophysics (35) 35
engineering (35) 35
física (34) 34
channel cross section: branching ratio: upper limit (33) 33
differential cross section: measured (33) 33
final state:jet lepton (33) 33
humans (33) 33
settore fis/04 - fisica nucleare e subnucleare (33) 33
hep-ex (32) 32
transverse momentum: missing-energy (32) 32
channel cross section: upper limit (31) 31
decay (29) 29
electroweak interaction (29) 29
leptonic decay [z0] (29) 29
mass spectrum: (29) 29
missing-energy [transverse momentum] (29) 29
sensitivity (29) 29
top: pair production (29) 29
lhc (28) 28
measured [differential cross section] (28) 28
numerical calculations: monte carlo (27) 27
standard model (27) 27
higgs particle: hadroproduction (25) 25
model (25) 25
transverse momentum (25) 25
channel cross section: measured (24) 24
index medicus (24) 24
phase space (24) 24
final state:jet dilepton (23) 23
hadron colliders (23) 23
luminosity (23) 23
medicine, general & internal (23) 23
physik (23) 23
searching (23) 23
structure (22) 22
higgs particle: hadronic decay (21) 21
monte carlo [numerical calculations] (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism;... 
MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | THERAPY | DISEASE | PREVENTION | DEEP-VEIN THROMBOSIS | IDRAPARINUX | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 11/2004, Volume 181, Issue 9, pp. 492 - 497
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 4, pp. 809 - 816
Summary Risks of recurrence and bleeding are highest during the first weeks of anticoagulant therapy for venous thromboembolism (VTE). We therefore examined... 
Stroke, Systemic or Venous Thromboembolism
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1105 - 1112
Journal Article
Medical Journal of Australia, ISSN 0025-729X, 12/2014, Volume 201, Issue 11, pp. 645 - 645
Journal Article